Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Wallace Rivers who wrote (24615)	8/17/1998 11:30:00 AM
From: bob zagorin	Read Replies (5) \| Respond to of 32384

my bull case for lgnd here would go something like this. reasons to buy now. 1. excellent science 2. broad pipeline moving forward 3. strong partnerships 4. good coverage on street 5. profits wiithin year 6. price decline more to do with sector than stock. caveats. 1. overall market conditions 2. AGN stock overhang 3. dilution i guess i think a stock like lgnd is more insulated from asia and russia than just about anything else but so far ws hasn't recognized this. i also think the AGN is clsoe to done (not sure). Sometime soon i think ws will start to change the way it values LGND, from a research biotech to an emerging pharmaceutical. we'll see.